Pharmacogenomics of Medication‐Induced Weight Gain and Antiobesity Medications

Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study

(2018) V. Chedid et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients

(2018) Xupeng Bai et al.   PSYCHOPHARMACOLOGY

Mechanisms, Pathophysiology, and Management of Obesity

(2017) Steven B. Heymsfield et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reward-Induced Eating: Therapeutic Approaches to Addressing Food Cravings

(2016) Candida J. Rebello et al.   ADVANCES IN THERAPY

FDA-Approved Anti-Obesity Drugs in the United States

(2016) Homayoun L. Daneschvar et al.   AMERICAN JOURNAL OF MEDICINE

Polymorphisms of theGRandHSD11B1genes influence body mass index and weight gain during hormone replacement treatment in patients with Addison's disease

(2016) Ágnes Molnár et al.   CLINICAL ENDOCRINOLOGY

Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance

(2016) Wai Johnn Sam et al.   JOURNAL OF CLINICAL PHARMACOLOGY

A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitus

(2016) Qingqin S. Li et al.   Pharmacogenetics and Genomics

Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches

(2016) Maite Solas et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Cytochrome P450 2C19polymorphisms and valproic acid-induced weight gain

(2015) M. Noai et al.   ACTA NEUROLOGICA SCANDINAVICA

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

(2015) JK Hicks et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study

(2015) Mojca Jensterle et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid

(2015) H. Li et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

(2015) Melanie J. Davies et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor

(2015) Daniel Antonio de Luis et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Pharmacogenetics of Obesity Drug Therapy

(2014) A.K. Guzman et al.   CURRENT MOLECULAR MEDICINE

Weight gain and antipsychotics: a drug safety review

(2014) Richard Musil et al.   Expert Opinion On Drug Safety

GRIK1 Genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink

(2014) Henry R. Kranzler et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans

(2014) Bronwyn S. Berthon et al.   NUTRITION RESEARCH

Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia

(2014) Shi Hyun Kang et al.   PSYCHIATRIC GENETICS

Weight change, genetics and antiepileptic drugs

(2013) Joseph Chukwu et al.   Expert Review of Clinical Pharmacology

Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study

(2012)   DIABETES CARE

Effect of the G-protein β3 subunit 825T allele on the change of body adiposity in obese female

(2012) I. C. Hwang et al.   DIABETES OBESITY & METABOLISM

Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia

(2012) John P. Houston et al.   JOURNAL OF CLINICAL PSYCHIATRY

Weight change associated with antiepileptic drugs

(2012) W. O. Pickrell et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of the Common -866G/A Polymorphism of the Uncoupling Protein 2 Gene on Weight Loss and Body Composition under Sibutramine Therapy in an Obese Taiwanese Population

(2012) Tun-Jen Hsiao et al.   Molecular Diagnosis & Therapy

Beta-Blockers and Weight Change in Patients With Chronic Heart Failure

(2011) Ben W.J. Boxall et al.   JOURNAL OF CARDIAC FAILURE

TNF-α −308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment

(2011) Hsiang-Hsuan Huang et al.   NEUROSCIENCE LETTERS

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin

(2009) M V Tzvetkov et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Diabetes medications and body weight

(2009) Joanna Mitri et al.   Expert Opinion On Drug Safety

Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1

(2009) Anna Secher et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

How to Use an Article About Genetic Association

(2009) John Attia et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication

(2009) Jochem G. Gregoor et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Olanzapine-induced weight gain is associated with the −759C/T and −697G/C polymorphisms of the HTR2C gene

(2009) B R Godlewska et al.   PHARMACOGENOMICS JOURNAL

Adrenergic β1 Receptor Polymorphism (Ser49Gly) Is Associated with Obesity in Type II Diabetic Patients

(2008) Shinpei Nonen et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN